Login
$UUUU
$6.01 -$0.03 (0.5%) After hours

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Sep 30, 2026
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
ASSETS
Current assets
Cash and cash equivalents
Marketable securities
Marketable securities (Notes 4 and 17)
Trade and other receivables, net, no allowance for credit losses as of September 30, 2026 and December 31, 2025 (Note 5)
Inventories (Note 6)
Prepaid expenses and other current assets
Property, plant and equipment and other assets held for sale, net (Note 7)
Total current assets
Other long-term receivables
Mineral properties, net (Note 7)
Property, plant and equipment, net (Note 7)
Inventory, Noncurrent
Operating lease right of use asset
Investments, net (Note 8)
Marketable securities (Notes 4 and 17)
Goodwill (Note 9)
Intangible assets, net (Note 9)
Other Assets, Noncurrent
Restricted cash (Note 11)
Other assets
Total assets
Current liabilities
Liabilities, Current
Accounts payable and accrued liabilities (Note 15)
Deferred revenue (Note 18)
Asset retirement obligations
Debt (Note 10)
Contingent consideration (Notes 17 and 19)
Other liabilities (Note 15)
Deposits for assets held for sale
Asset retirement obligation and other liabilities held for sale (Note 8)
Total current liabilities
Convertible senior notes, net (Notes 10 and 17)
Asset retirement obligations (Note 11)
Deferred revenue
Contract with Customer, Liability
Deferred tax (Note 14)
Other liabilities
Total liabilities
Equity
Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 264,828 and 240,366 as of September 30, 2026 and December 31, 2025, respectively
Accumulated deficit
Accumulated other comprehensive income (loss)
Total shareholders’ equity
Non-controlling interest
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support